Title:
ANTIBODY BINDING TO CANNABINOID RECEPTOR CB1 AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2024/022478
Kind Code:
A1
Abstract:
An antibody specifically binding to CB1 or an antigen-binding fragment thereof, a pharmaceutical composition comprising the antibody or the antigen-binding fragment thereof, a nucleic acid molecule encoding the antibody or the antigen-binding fragment thereof and a host cell comprising the nucleic acid molecule, and therapeutic and diagnostic use of these antibodies or the antigen-binding fragments thereof.
Inventors:
MA YANBIN (CN)
JIN LEI (CN)
WANG SIQIN (CN)
CHEN DAKAI (CN)
HU SHAOPING (CN)
CHEN LANLAN (CN)
JIN HOUCONG (CN)
SHEN HONGXIA (CN)
SUN GAO (CN)
KANG LISHAN (CN)
JIN LEI (CN)
WANG SIQIN (CN)
CHEN DAKAI (CN)
HU SHAOPING (CN)
CHEN LANLAN (CN)
JIN HOUCONG (CN)
SHEN HONGXIA (CN)
SUN GAO (CN)
KANG LISHAN (CN)
Application Number:
PCT/CN2023/109811
Publication Date:
February 01, 2024
Filing Date:
July 28, 2023
Export Citation:
Assignee:
CHANGCHUN GENESCIENCE PHARMACEUTICAL CO LTD (CN)
International Classes:
C07K16/28; A61K39/395; A61P3/04; A61P3/06; A61P3/10; G01N33/68
Domestic Patent References:
| WO2013006729A2 | 2013-01-10 | |||
| WO1992002640A1 | 1992-02-20 |
Foreign References:
| CN108513615A | 2018-09-07 | |||
| CN106232626A | 2016-12-14 | |||
| JP2021525059A | 2021-09-24 | |||
| US20160145333A1 | 2016-05-26 |
Attorney, Agent or Firm:
CCPIT PATENT AND TRADEMARK LAW OFFICE (CN)
Download PDF: